dorsaVi Limited (ASX:DVL) has received firm commitments to raise A$3.0 million before costs through a placement of 136,363,636 fully paid ordinary shares at an issue price of $0.022 per share, with proceeds directed toward expanding its humanoid robotics data capabilities and advancing its RRAM semiconductor development program.
Key Points
- Firm commitments received for a A$3.0 million placement at $0.022 per share to new and existing sophisticated, professional, and high-net-worth investors.
- 136,363,636 new fully paid ordinary shares to be issued, with 68,181,818 free attaching unlisted options on a 1-for-2 basis, exercisable at $0.045 and expiring three years from the date of issue.
- The first RRAM-CMOS validation chip has completed front-end and middle-of-line fabrication on TSMC's CMOS process, with RRAM integration and energy testing now under way.
- Settlement of the new shares is expected to occur on or around Monday, 19 October 2026.
- The placement was led by 62 Capital, which will receive a fee of 6% of the gross amount raised, together with 24,000,000 unlisted options exercisable at $0.045 per option.
Placement Structure and Pricing
Under the placement, dorsaVi will issue 13,363,636 new shares under ASX Listing Rule 7.1 capacity and 123,300,000 new shares under ASX Listing Rule 7.1A capacity. The issue price of $0.022 per share represents a 12% discount to the last traded price of $0.025 on 1 October 2026, a 15% discount to the 10-day VWAP of $0.026, and an 8% discount to the 15-day VWAP of $0.024, both calculated to and including 1 October 2026. The Broker Options issued to 62 Capital will be issued in accordance with the company's placement capacity under ASX Listing Rule 7.1.
RRAM-CMOS Chip Fabrication Progress
According to the filing, the first RRAM-CMOS validation chip has completed front-end and middle-of-line fabrication on TSMC's CMOS process. The wafers are advancing into proprietary RRAM integration, with the objective of generating silicon data intended to guide the company's planned progression toward future 22-nm RRAM-CMOS development. The RRAM development program is conducted in partnership with NTU and ITRI, targeting low-power, on-device intelligence for systems operating under tight constraints on power, connectivity, and size.
Use of Placement Proceeds
The filing states that proceeds will be used to expand dorsaVi's clinical-grade human movement data library and bespoke data-capture capability, encompassing wearable sensors and Video AI, to meet requirements from humanoid robotics developers for balance, coordination, and recovery data. Funds will also target smart-soldier systems, aerial drone, and autonomous underwater vehicle applications. The filing notes that these areas represent targeted commercial and technical exploration rather than completed integrated products. The balance of proceeds will fund partner evaluations, general working capital, and the costs of the offer.



Please wait processing your request...